Don't know much about those other ticker, though they look similar, I wouldn't see it as an orchestrated buy up on US pot stocks. Medmen is based off US but has not recouped its losses from last sell off or should I say, instead, a contrarian to your "stair case"
point. Hmmm, is it because it such a Madmen mismanaged company? If your theory is right, it should spike as the others you mentioned; but no. So I'm betting on your other theory you mentioned John.
One thing I believe, is that when this company reports their financial at the end of the month, this will be more undervalued than before, therefore should naturally separate it self from that herd.
News 
Market Data 
Discover 
